Temps Différé
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
38,52 USD | -0,72 % | -4,64 % | -16,48 % |
Métier
Nombre d'employés: 255
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Ian Mortimer
CEO | Chief Executive Officer | 48 | 21/10/13 |
Simon Pimstone
FOU | Founder | 56 | 05/11/96 |
Sherry Aulin
DFI | Director of Finance/CFO | 40 | 01/01/11 |
Chief Tech/Sci/R&D Officer | - | 23/08/21 | |
Sheila M. Grant
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/20 |
Jodi Regts
IRO | Public Communications Contact | - | 01/12/15 |
Corporate Officer/Principal | - | 17/08/20 | |
Andrea DiFabio
LAW | General Counsel | 55 | 07/11/22 |
James Empfield
PRN | Corporate Officer/Principal | - | 01/02/16 |
Corporate Officer/Principal | 63 | 01/03/01 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Clarence Machado
BRD | Director/Board Member | 60 | 05/11/20 |
Mohammad Azab
BRD | Director/Board Member | 68 | 01/10/03 |
Justin Gover
BRD | Director/Board Member | 53 | 08/08/23 |
Gary Patou
BRD | Director/Board Member | 65 | 01/01/04 |
Simon Pimstone
FOU | Founder | 56 | 05/11/96 |
Steven Gannon
BRD | Director/Board Member | 62 | 21/05/15 |
Ian Mortimer
CEO | Chief Executive Officer | 48 | 21/10/13 |
Dawn Svoronos
BRD | Director/Board Member | 70 | 27/09/16 |
Director/Board Member | 66 | 03/06/21 | |
Gillian Cannon
BRD | Director/Board Member | 60 | 08/08/23 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 75 468 883 | 74 291 475 ( 98,44 %) | 0 | 98,44 % |
Coordonnées société
Xenon Pharmaceuticals, Inc.
3650 Gilmore Way Suite 200
V5G 4W8, Burnaby
+604 484 3300
http://www.xenon-pharma.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-17,99 % | 2,93 Md | |
+10,88 % | 115 Md | |
+12,34 % | 106 Md | |
-4,40 % | 24,69 Md | |
-2,33 % | 21,97 Md | |
-6,03 % | 19,27 Md | |
-12,85 % | 17,56 Md | |
-40,50 % | 17,32 Md | |
+6,38 % | 14,03 Md | |
+31,27 % | 12,13 Md |
- Bourse
- Actions
- Action XENE
- Société Xenon Pharmaceuticals Inc.